
AbbVie Menstrual Migraine Drug Trial Shows Positive Phase 3 Results
AbbVie has reported positive results from its menstrual migraine drug “Atogepant”. It has met the primary endpoint and all eight
AbbVie has reported positive results from its menstrual migraine drug “Atogepant”. It has met the primary endpoint and all eight ranked secondary …
Human rabies exposures in US communities have increased since July, prompting the Centers for Disease Control and Prevention (CDC) to issue a …
The UK is moving toward a major update of how artificial intelligence is regulated in healthcare, with recommendations calling for continuous monitoring, …
A new study has found an association between paracetamol use during pregnancy and differences in reproductive-organ development among baby girls. Researchers reported …
Novo Nordisk has halted two more late-stage studies of its experimental heart disease drug ziltivekimab, dealing another setback to the Danish drugmaker’s …
UK’s largest private hospital operator, Spire Healthcare, has agreed to go into private ownership with a £1.03 billion acquisition by an investor …
The Walmart frozen berry recall has expanded its list of recalls with a new announcement. One lot of Great Value Organic Triple …
UnitedHealthcare is making major changes in its policy that will remove prior authorization requirements from about 1,700 treatments beginning October 1, 2026. …
Nestle and the private equity firm Yellow Wood Partners have reached an agreement for a $1 billion acquisition deal. The Nestle and …
Dyson has entered the smart oral-care market. The new electric toothbrush by Dyson that combines a built-in camera, artificial intelligence (AI), sonic …
Novartis has temporarily halted eight clinical trials of its experimental CD19-targeted CAR-T therapy, rap-cel (YTB323), after three patients died from complications associated …
The pharma giant Eli Lilly is continuing its acquisition spree by adding another firm to the list. Eli Lilly has agreed to …

AbbVie has reported positive results from its menstrual migraine drug “Atogepant”. It has met the primary endpoint and all eight

Human rabies exposures in US communities have increased since July, prompting the Centers for Disease Control and Prevention (CDC) to

The UK is moving toward a major update of how artificial intelligence is regulated in healthcare, with recommendations calling for

A new study has found an association between paracetamol use during pregnancy and differences in reproductive-organ development among baby girls.

Novo Nordisk has halted two more late-stage studies of its experimental heart disease drug ziltivekimab, dealing another setback to the

UK’s largest private hospital operator, Spire Healthcare, has agreed to go into private ownership with a £1.03 billion acquisition by

The Walmart frozen berry recall has expanded its list of recalls with a new announcement. One lot of Great Value

UnitedHealthcare is making major changes in its policy that will remove prior authorization requirements from about 1,700 treatments beginning October

Nestle and the private equity firm Yellow Wood Partners have reached an agreement for a $1 billion acquisition deal. The

Dyson has entered the smart oral-care market. The new electric toothbrush by Dyson that combines a built-in camera, artificial intelligence

Novartis has temporarily halted eight clinical trials of its experimental CD19-targeted CAR-T therapy, rap-cel (YTB323), after three patients died from

The pharma giant Eli Lilly is continuing its acquisition spree by adding another firm to the list. Eli Lilly has